Aspiration and Biopsy Needles Market Research Report: By Type (Core Needle, Fine Needle), Procedure (Image-Guided, Non-Image-Guided), Application (Breast Biopsy, Lung Biopsy, Prostate Biopsy, Bone and Bone Marrow Biopsy), End User (Hospitals, Diagnostic Centers, Clinics, Research and Academic Institutes)
NEW YORK, April 06, 2020 (GLOBE NEWSWIRE) -- The major driver for the aspiration and biopsy needles market share is the increasing incidence of cancer around the world. Around 12.7 million new cancers were diagnosed in 2008, according to the World Health Organization (WHO), and this number is expected to cross 21.4 million by 2030. Among cancers, those of the lungs, breasts, liver, stomach, colon, and rectum are the deadliest.
Thus, with the rising number of people falling victim to the disease and the significance of early diagnosis for effective treatment, the global aspiration and biopsy needles market is growing. Witnessing a 7.2% CAGR during 2020–2030 (forecast period), the industry revenue is expected surge from $801.5 million in 2019 to $1,717.9 million by 2030.
Get the Sample Copy of this Report at: https://www.psmarketresearch.com/market-analysis/aspiration-and-biopsy-needles-market/report-sample
Hospitals to be Largest End User till 2030
Hospitals are expected to be the largest end users in the aspiration and biopsy needles market till 2030. Such establishments employ skilled and highly trained healthcare professionals and have more facilities, which is why patients prefer them over diagnostic centers and clinics.
Core needle held the larger revenue share in 2019, as this type of biopsy makes the differentiation between invasive and in situ breast cancer easier. Additionally, the identification of harmless lesions also becomes more efficient with core-needle biopsies.
During the forecast period, the image-guided bifurcation would experience faster advance in the aspiration and biopsy needles market. This is ascribed to the lesser chances of errors that image-guided biopsies carry over the non-image-guided technique. Further, as image-guided biopsies are minimally invasive procedures, not requiring large incisions, the preference for them is high.
Browse report overview with 287 tables and 57 figures spread through 245 pages and detailed TOC on “Aspiration and Biopsy Needles Market Research Report: Industry Size, Share, Development and Demand Forecast to 2030” at: https://www.psmarketresearch.com/market-analysis/aspiration-and-biopsy-needles-market
Breast biopsy held the largest value share in the industry during the historical period (2014–2019), as the incidence of breast cancer is rapidly escalating around the world. Additionally, currently, most cases in low- and middle-income countries are detected at later stages, thus raising the demand for early diagnosis.
Asia-Pacific (APAC) is predicted to display the highest CAGR, of 8.3%, during the forecast period. This quick growth of the aspiration and biopsy needles market in the region is attributed to the increasing prevalence of cancer here. As per the 2017 Global Burden of Disease report published by the WHO, East Asia accounted for 28.9% of the cancer deaths across the world that year.
Make Enquiry Before Purchase at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=aspiration-and-biopsy-needles-market
Market Players Launching New Products to Strengthen their Position
Players in the aspiration and biopsy needles market have launched numerous products in the past, to gain a larger customer base and market share. For instance, in September 2018, Merit Medical Systems Inc. launched the Huntington, Madison, Westbrook, Madison Mini, and Kensington systems for narrow-access, upper-spine, and deep-bone biopsies.
The major companies operating in the global aspiration and biopsy needles market are Olympus Corporation, Stryker Corporation, Boston Scientific Corporation, Argon Medical Devices Inc., Becton, Dickinson and Company, Medtronic plc, CONMED Corporation, Merit Medial System Inc., Sterylab s.r.l., Cook Medical LLC, and Cardinal Health Inc.
More Reports of Life Sciences by P&S Intelligence
Human Insulin Market
The human insulin market in APAC is expected to witness fastest growth, due to rising prevalence of diabetes, unhealthy lifestyle choices due to rapid urbanization, and growing aging population in the countries like China and India. Additionally, major players as a part of their business strategy are investing in the untapped market of the region leading to its fastest growth.
https://www.psmarketresearch.com/market-analysis/human-insulin-market
Auto-Injectors Market
According to the study, the global auto-injectors market is likely to grow significantly during the forecast period, due to increasing prevalence of anaphylaxis, increasing cases with multiple sclerosis, rising geriatric population and high production of biologics.
https://www.psmarketresearch.com/market-analysis/auto-injectors-market
About P&S Intelligence
P&S Intelligence is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.
Contact:
P&S Intelligence
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com